Type II: UCF I-Corps Site - enhancing technology commercialization to develop a world-class innovation ecosystem
Type II: UCF I-Corps Site - enhancing technology commercialization to develop a world-class innovation ecosystem
批准号:
1735841
负责人:
Thomas O'Neal
金额:
$29.93万
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2022-10-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This project extends the University of Central Florida's (UCF) I-Corps Site for an additional three years beyond their initial three-year award. NSF Innovation Corps (I-Corps) Sites are NSF-funded entities established at universities whose purpose is to nurture and support multiple, local teams to transition their technology concepts into the marketplace. Sites provide infrastructure, advice, resources, networking opportunities, training and modest funding to enable groups to transition their work into the marketplace or into becoming I-Corps Team applicants. I-Corps Sites also strengthen innovation locally and regionally and contribute to the National Innovation Network of mentors, researchers, entrepreneurs and investors. There are two types of I-Corps Site proposals. Type I proposals are submitted by institutions that have not had prior funding as an I-Corps Site. These proposals may request $100,000 per year for up to five years. Type II proposals are submitted by institutions that have had prior funding as an I-Corps Site. These proposals may request up to $100,000 per year for up to three years. The intellectual merits of the I-Corps Site renewal project at UCF include the capture and curation of a deep understanding of (1) the processes, methodologies and programs for entrepreneurship education and technology commercialization, (2) Best practices for transitioning research from the bench top into the marketplace, (3) and distributing this knowledge to collaborators, partners, and affiliates throughout the NIN, and (4) development and adaptation of programs for specialty cohorts supporting local clusters and targeted populations. Additional knowledge and understanding will be gained through the collection of longitudinal data following I-Corps participants after they have completed the curriculum. UCF is an active and engaged partner in the Central Florida innovation ecosystem. The broader impacts from this project directly contribute to the broader community understanding of innovation-based economic development and the importance of research and commercialization. This is critically important to a community that is dependent on tourism and hospitality and the associated lower paying jobs in the region. Building on the initial successes of the UCF I-Corps Site program, successful commercialization of research and inventions generated at the leading research institutions and affiliate organizations in the region, this renewal project has the potential to significantly impact the regional economy. Further, with curriculum that effectively serves Hispanic populations, there is the potential to produce major social and economic impact on a national level. Florida has the third largest Hispanic population in the U.S., with nearly 25% of UCF student population and 34% of Florida business owners being of Hispanic origin, making this an ideal location to develop, deploy, and refine the curriculum.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Enabling academic entrepreneurship: the I-Corps experience
促进学术创业:I-Corps 经验
DOI:
10.1108/et-03-2019-0045
发表时间:
2020
期刊:
Education + Training
影响因子:
--
作者:
[Al Haddad, Serina, O'Neal, Thomas, Batarseh, Issa, Martoncik, Amber]
通讯作者:
Martoncik, Amber
I-Corps: Multifunctional Additives with Controlled Release Agents
-
批准号:1660010
-
项目类别:Standard Grant
-
资助金额:$5.0万
-
财政年份:2016
-
负责人:Thomas O'Neal
-
依托单位:
University of Central Florida I-Corps Sites: Enhancing Technology Commercialization to Develop a World-Class Innovation Ecosystem
-
批准号:1347356
-
项目类别:Standard Grant
-
资助金额:$30.0万
-
财政年份:2014
-
负责人:Thomas O'Neal
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于生境成像与深度学习联合临床特征构建II型卵巢癌术前淋巴结转移预测模型的研究
-
批准号:2026JJ81984
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨石平
-
依托单位:
鸡软骨非变性II型胶原高效制备和靶向递送的关键技术开发与应用示范
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵子方
-
依托单位:
青蒿琥酯协同TROP2/线粒体级联靶向的NIR-II多模态诊疗用于晚期TNBC精准诊断与治疗的机制研究
-
批准号:2026JJ30126
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨沙
-
依托单位:
苏合颗粒治疗慢性萎缩性胃炎的临床(II期)评价关键技术研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蒋晓波
-
依托单位:
医工融合策略下的新型NIR-II有机探针用于中晚期肝癌精准诊断与协同治疗
-
批准号:2026JJ30093
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈国栋
-
依托单位:
用于肺纤维化实时动态监测的NIR-II稀土纳米探针研究
-
批准号:JCZRLH202600246
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
以数据与知识双驱动的NIR-II荧光成像智能分析新范式与基础算法
-
批准号:JCZRMS202600521
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
桥粒斑蛋白调控II型肺泡上皮细胞凋亡易感性而促进特发性肺纤维化形成的机制研究
-
批准号:2026JJ70015
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:彭菲
-
依托单位:
光敏型钌(II)配合物与喜树碱协同给药抗肝癌活性及作用机制研究
-
批准号:2026JJ81924
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谷依盈
-
依托单位:
草鱼免疫球蛋白与GCRV-II互作机制及高效疫苗创制
-
批准号:JCZRQNA202600094
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: